Higher Risk of Cancer Recurrence Unlikely With TNFi Therapy in RA


One caveat: because several risk estimates reached higher confidence intervals, a clinically meaningful risk cannot be completely ruled out.

Reference1. Raaschou P, Söderling J, Turesson C, Askling J; ARTIS Study Group. Tumor necrosis factor inhibitors and cancer recurrence in Swedish patients with rheumatoid arthritis: a nationwide population-based cohort study. Ann Intern Med. 2018;169:291-299. doi: 10.7326/M17-2812.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.